Evidence map›Paper›PMID 36006443›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2022

An EANM position paper on the application of artificial intelligence in nuclear medicine.

Roland Hustinx, Jan Pruim, Michael Lassmann, Dimitris Visvikis

Abstract readConsensus Statement
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Comparison of MRI vs. [Journal of clinical medicine · 2023
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roland HustinxDivision of Nuclear Medicine and Oncological Imaging, University Hospital of Liège & GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium.
Jan PruimMedical Imaging Center, Dept. of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.pruim@umcg.nl.ORCID http://orcid.org/0000-0002-8323-6187
Michael LassmannDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Dimitris VisvikisLaTIM, INSERM, UMR 1101, University of Brest, Brest, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is coming into the field of nuclear medicine, and it is likely here to stay. As a society, EANM can and must play a central role in the use of AI in nuclear medicine. In this position paper, the EANM explains the preconditions for the implementation of AI in NM and takes position.

Indexed as

Nuclear MedicineArtificial IntelligenceHumansRadionuclide ImagingArtificial intelligenceEANMNuclear medicine

Identifiers

PMID36006443
PMCPMC9668762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.